Pre-made Besilesomab benchmark antibody (Radiolabelled antibody, anti-CEACAM8/NCA-95 therapeutic antibody, Anti-CD66b/CD67/CGM6 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Besilesomab benchmark antibody (Radiolabelled antibody, anti-CEACAM8/NCA-95 therapeutic antibody, Anti-CD66b/CD67/CGM6 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Besilesomab (trade name Scintimun) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect inflammatory lesions and metastases.[1] It binds to an immunoglobulin, IgG1 isotype. SCINTIMUN has been used since 1992 mainly in Hungary, Czech Republic, and Switzerland on the basis of local marketing authorizations, and in Germany (on the basis of individual prescription). Between 1992 and 2009, an estimated 90,000 patients has been studied. In 2009, the EMEA has approved SCINTIMUN for marketing in all European countries.[

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-756-1mg	1mg	3090
GMP-Bios-INN-756-10mg	10mg	Inquiry
GMP-Bios-INN-756-100mg	100mg	Inquiry
GMP-Bios-INN-756-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Besilesomab Biosimilar, Radiolabelled Antibody, Anti-Ceacam8/NCA-95 Antibody: Anti-CD66b/CD67/CGM6 therapeutic antibody	Besilesomab
INN Name	Besilesomab
Target	CEACAM8
Format	Radiolabelled antibody
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	IgG1 - kappa
VD LC	IgG1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Iba Molecular Imaging (Louvain- la-Neuve Belgium)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0